Specific genetic alterations of breast tumors lead to Yo paraneoplastic cerebellar degeneration


Previous findings of research groups in Paris and Lyon, France, investigated the genetic basis of paraneoplastic cerebellar degenerations with anti-Yo antibodies (Yo-PCD) associated with ovarian cancers. Recent results suggest that this auto-immune response against neuronal antigens expressed by tumor cells is also associated with a distinct class of hormone receptor-negative HER2-enriched breast cancers.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.